Affiliation:
1. Department of Medicine, Division of Gastroenterology, Stanford University School of Medicine, Redwood City
2. Department of Pediatrics, Center for Policy, Outcomes, and Prevention, Stanford University School of Medicine
3. Department of Pediatrics and Department of Health Policy, Stanford University School of Medicine, Stanford, CA
Abstract
Background:
Gastroesophageal reflux disease (GERD) is common. Treatment is to manage symptoms, but medication nonadherence is common. To date, little emphasis has been on understanding patient behaviors and reasons for medication nonadherence.
Methods:
We performed a cross-sectional survey study among expert gastroenterologists specializing in esophageal disease. Survey studies consisted of a 6-item questionnaire measuring physician knowledge of patient activation, the Clinician Support for Patient Activation Measure (CS-PAM), and an adapted 20-item Patient Assessment of Chronic Illness Care (PACIC). All question stems were specified to GERD management.
Results:
Thirty-six experts participated. Most indicated hearing the term patient engagement before this survey (88.9%), but fewer were aware of the term patient activation (33.3%). Respondents were then made aware of the clinical significance of patient activation and asked, based on this knowledge, the likelihood that patients' activation level before the clinic would impact their communication. Responses varied between “to a great extent” and “not at all.” Overall, CS-PAM activation scores were high, indicating a high level of support for patient activation. Lastly, respondents indicated their frequency of participating in partnership-building behaviors with patients. More than half (52.8%) of expert physicians “almost always” asked how GERD affected their lives, while less often asked patients about their health habits (22.2%), help set specific goals to improve their eating or exercise lifestyle (19.4%), or refer patients to a dietician, health educator, or counselor for their GERD (11.1%).
Conclusion:
Patient activation is an important strategy and may provide a behavioral approach to address medication adherence in GERD.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference14 articles.
1. The changing epidemiology of gastroesophageal reflux disease: Are patients getting younger?;Yamasaki;J Neurogastroenterol Motil,2018
2. Effectiveness of proton pump inhibitors in the treatment of patients with endoscopic esophagitis;Gashi;Med Arh,2010
3. Noncompliance is an impact factor in the treatment of gastroesophageal reflux disease;Domingues;Expert Rev Gastroenterol Hepatol,2014
4. Patient activation and the use of information to support informed health decisions;Hibbard;Patient Educ Couns,2017
5. Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy;Balbale;Patient Exp J,2018